Thierry Poynard - Concepedia

Author

Thierry Poynard

Also Known As

Gilles Pialoux, Jean-Baptiste Julla, Ole H. Petersen, P Opolon, Pialoux, Gilles, Poynard, Poynard, T, Poynard, T., T POYNARD, T Poynard

644

Publications

60.6K

Citations

111

H-Index

179

Concepts

All Affiliations

Sorbonne Université Pitié-Salpêtrière Hospital Assistance Publique – Hôpitaux de Paris Inserm Hôpital Antoine-Béclère

About

Thierry Poynard is an author at Sorbonne Université specializing in medicine, hepatology, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	69	143	32K
2	Health Sciences	22	27	6K
3	Public Health	8	8	1.5K
4	Engineering	1	1	30
5	Natural Sciences	1	1	13

Thierry Poynard

269

Publications

49.2K

Citations

102

H-Index

Page 1

	Year	Citations
An Algorithm for the Grading of Activity in Chronic Hepatitis C Pierre Bédossa, Thierry Poynard Hepatology HepatologyHepatitis CViral HepatitisLiver PhysiologyHistopathology	1996	4K
Natural history of liver fibrosis progression in patients with chronic hepatitis C Thierry Poynard, Pierre Bédossa, P Opolon The Lancet Liver Fibrosis ProgressionHepatologyHepatitis CViral HepatitisLiver Physiology	1997	3K
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus Thierry Poynard, Patrick Marcellin, Samuel S. Lee, The Lancet Interferon α2BHepatologyHepatitis CHepatitis C VirusViral Hepatitis	1998	2.3K
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease Vlad Ratziu, Frédéric Charlotte, A. Heurtier, Gastroenterology HepatologyNonalcoholic Fatty Liver DiseaseLiver PhysiologyHistopathologyDiagnosis	2005	2K
Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study Françoise Imbert‐Bismut, Vlad Ratziu, Laurence Piéroni, The Lancet Liver FibrosisBiochemical MarkersHepatologyHepatitis CViral Hepatitis	2001	1.4K
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients Yves Benhamou, Marie Bochet, Vincent Di Martino, Hepatology	1999	1.2K
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C Thierry Poynard, John G. McHutchison, Michael P. Manns, Gastroenterology Liver FibrosisHepatologyHepatitis CViral HepatitisLiver Physiology	2002	1.1K
Adherence to combination therapy enhances sustained response in genotype-1–infected patients with chronic hepatitis C John G. McHutchison, Michael P. Manns, Keyur Patel, Gastroenterology HepatologyHepatitis CGenotype-1–infected PatientsViral HepatitisCombination Therapy Enhances	2002	977
Liver fibrosis in overweight patients Vlad Ratziu, Philippe Giral, Frédéric Charlotte, Gastroenterology ObesityMetabolic Associated SteatohepatitisBody CompositionHepatologyOverweight Patients	2000	969
Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression Gary L. Davis, Miriam J. Alter, Hashem B. El‐Serag, Gastroenterology HepatologyAgingHealthy AgingViral HepatitisHepatitis C	2009	881

Page 1